Moderated afternoon session of Rep. Susan W. Brooks, “Connecting Classrooms and Careers” program.
Signed on to a joint letter to the President urging him to focus on ag biotech issues in his upcoming meetings with President Xi Jinping of China.
Participated with IMDMC in Legislative Roundtable, Indianapolis
Participated in Hoosiers Work for Health/We Work for Health PhRMA Partnership Fly-In to Washington D.C.
Requested Indiana Congressional Delegation to sign-on to bi-partisan letter encouraging fair and balanced patent reform consideration in HR 9.
Met with Rep. Susan W. Brooks at BIO Convention in Philadelphia, provided tour of Indiana booth in the conference exhibit hall
Awarded Rep. Susan W. Brooks IHIF’s Legislator of the Year Award for outstanding service to Indiana’s health science sector
Signed on to joint-association letter supporting H.R. 1078, the FDA Safety Over Sequestration (SOS) Act
Participated in Hoosiers Work for Health Award to Rep. Susan W. Brooks
Signed on to Healthcare Leadership Forum letter to repeal IPAB
Participated in the BIO Fly-In to Washington, D.C. – met with nine of Indiana’s eleven offices.
Signed on to the Declaration Supporting Incentives for Medical Innovation in Trade Agreements organized by the Global Colon Cancer Association and the Information Technology and Innovation Foundation
Indiana Expanding Exports and Creating Jobs – Fact Sheet with information on TTIP and TPA impacts on state.
Signed on to National Osteoporosis Foundation letter to Congress supporting Medicare Part D.
IHF signed on to a letter to the Administration emphasizing the importance of strong IP and data protections for medicines. Letter was initiated by the Global Colon Cancer Association and the Information Technology and Innovation Foundation.
IHIF co-hosted our 4th Annual Legislative Breakfast Briefing (agenda) on January 28th. Co-Hosts include IMDMC and Hoosiers Work for Health/PhRMA
IHIF shared concerns over Senator Elizabeth Warren’s “Medical Innovation Act”.
IHIF provided informational testimony on HB 1065 – Use of investigational drugs, biologics, and devices. Also expressed concern over SB 66.
- Sent letters outlining concerns to Rep. Culver and Rep. Clere (see points included in testimony), Sen. P. Miller, and Sen. Charbonneau
- Copy of IHIF testimony
- BIO “Points to Consider” around Patient Access
IHIF signs on to letter encouraging US legislators to proceed with caution when considering making changes to patent legislation
IHIF signs on to letter to US legislators highlighting the success of Medicare Part D and urging Congress to reject any proposals that would undermine the current program’s success in holding down premiums and taxpayer costs, while still producing high satisfaction rates among enrollees.